Expression Profile of Endoglin in Different Grades of Endometrial Cancer-Reference-Cited by-同舟云学术

Expression Profile of Endoglin in Different Grades of Endometrial Cancer

Published:2019-01-08 Issue:12 Volume:19 Page:990-995
ISSN:1389-2010
Container-title:Current Pharmaceutical Biotechnology
language:en
Short-container-title:CPB

Author:

Opławski Marcin¹,Dziobek Konrad²,Adwent Iwona³,Dąbruś Dariusz³,Grabarek Beniamin¹,Zmarzły Nikola¹,Plewka Andrzej¹,Boroń Dariusz³

Affiliation:

1. Department of Molecular Biology, School of Pharmacy with the Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Sosnowiec, Poland

2. Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialist Hospital, Krakow, Poland

3. Department of Midwifery, Opole Medical High School, Opole, Poland

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Biotechnology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological Roles of CCL18 in Pan‑Cancer and Its Potential Value in Endometrial Cancer;Molecular Biotechnology;2024-05-30

2. Targeting the Transforming Growth Factor-beta Signaling Pathway in the Treatment of Gynecologic Cancer;Current Cancer Drug Targets;2023-01

3. The Mutually Mediated Chloride Intracellular Channel Protein 1 (CLIC1) Relationship between Malignant Cells and Tumor Blood Vessel Endothelium Exhibits a Significant Impact on Tumor Angiogenesis, Progression, and Metastasis in Clear Cell Renal Cell Carcinoma (ccRCC);Cancers;2022-12-03

4. Canonical TGFβ Signaling and Its Contribution to Endometrial Cancer Development and Progression—Underestimated Target of Anticancer Strategies;Journal of Clinical Medicine;2021-08-30

5. Osthole suppresses the proliferation and induces apoptosis via inhibiting the PI3K/AKT signaling pathway of endometrial cancer JEC cells;Experimental and Therapeutic Medicine;2021-08-13